Elite Pharmaceuticals Inc (ELTP)

[lasers]

That would be correct. Purdue has the original "Embeda" 1-bead ADT Patent and they wisely did not pursue Commercialization because they knew it was not engineeringly feasible.

Alpharma/King simply copied the Purdue Patent and were sued successfully by Purdue after the Pfizer acquisition. Purdue had nothing to lose and all to gain just in case Pfizer/Alpharma/King could find a way to make "Embeda" stable. Pfizer/Alpharma/King has been trying unsuccessfully since 2010/2011 to make "Embeda" 1-bead stable. Embeda's Agonist ER Polymer and Antagonist Sequestering Polymer are always subjected to extruder fusion damaging heat and mechanical forces causing leaking Agonist and Antagonist.

$ELTP 2-bead ADTs ELI200/ELI201/ELI202/ELI216 are a completely different technology being modular and parallel so that the Agonist ER Polymer and Antagonist Sequestering Polymer are never subjected to damaging heat and mechanical forces but simply blended together gently as a final manufacturing step.

Very simple to understand Engineering 101!!!!